Biography
Sharon Elad, DMD, MSc, is a Professor of Dentistry at the University of Rochester, where she is Chair of the Division of Oral Medicine at the Eastman Institute for Oral Health (EIOH), and a Principal Consultant for Hospital Dentistry at University of Rochester Medical Center, Rochester, NY.
Dr. Elad runs Oral Medicine services which are focused on the diagnosis and non-surgical management of medically-related disorders or conditions affecting the oral and maxillofacial region. This includes oral mucosal diseases, complications of cancer or cancer therapy, burning mouth syndrome, and salivary gland disorders, among others.
Dr. Elad is the Head of educational courses for residents and students at EIOH focusing on oral medicine and dental management of medically complex patients. Dr. Elad has performed as the principle investigator of several studies, including multi-central multi-national studies, mostly in the fields of oral medicine, hematology and oncology. Dr. Elad has published widely on oral complications of cancer treatment, such as mucositis, osteonecrosis of the jaw, and chronic graft-versus-host disease, as well as dental management of these patients. One of Dr. Elad's topics of interest is the use of photobiomodulation (laser) therapy for oral diseases.
Along her career Dr. Elad was elected to several national and international roles. This includes being elected to serve as Co-Chair, and subsequently as the Chair of the mucositis study group (MSG) of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO). Additionally, Dr. Elad was a board member of MASCC/ISOO, and a member of the MASCC/ISOO Guidelines Committee. Currently, she is the Chair of the Oral Care Study Group of this societies. Dr. Elad is among the select few who have received the Honorary Diplomate Award from the American Board of Oral Medicine.
Publications
Journal Articles
11/10/2022
Blanchard A, Yarom N, Levi L, Cheng KKF, Bossi P, Zadik Y, Elad S, . "Clinicians' experience with topical benzydamine and morphine for the management of oral mucositis: adverse effects and barriers." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2022 Nov 10; Epub 2022 Nov 10.
5/31/2022
Lorini L, Perri F, Vecchio S, Belgioia L, Vinches M, Brana I, Elad S, Bossi P. "Confounding factors in the assessment of oral mucositis in head and neck cancer." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2022 May 31; Epub 2022 May 31.
2022
Robijns J, Nair RG, Lodewijckx J, Arany P, Barasch A, Bjordal JM, Bossi P, Chilles A, Corby PM, Epstein JB, Elad S, Fekrazad R, Fregnani ER, Genot MT, Ibarra AMC, Hamblin MR, Heiskanen V, Hu K, Klastersky J, Lalla R, Latifian S, Maiya A, Mebis J, Migliorati CA, Milstein DMJ, Murphy B, Raber-Durlacher JE, Roseboom HJ, Sonis S, Treister N, Zadik Y, Bensadoun RJ. "Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022." Frontiers in oncology.. 2022 12:927685. Epub 2022 Aug 30.
VIEW ALL PUBLICATIONS